Indeed, numerous studies have identified several molecules/drugs which can treat ALS by modulating the PGC-1α pathway (Table 3), which offers a promising prospect for targeting PGC-1α as effective treatment strategies. Here, PPARGC1A is linked to amyotrophic lateral sclerosis.